Zoom’s investment narrative has evolved beyond the post-pandemic return-to-office debate. Management highlighted during its Q3 FY2026 earnings call that revenue from its AI-enabled features grew 45% year-over-year, contributing roughly 18% of total bookings. The company now markets its generative AI meeting assistant and real-time translation services as key differentiators, aiming to drive 20% annual growth in enterprise subscriptions over the next two years. Investors will be watching adoption metrics for these modules in the large-cap segment, where average contract values exceed $120,000.

Zoom holds a 9% equity position in AI specialist Anthropic, an investment initially valued at $1.1 billion. This stake offers potential upside tied to Anthropic’s anticipated commercial launch of its Claude 3 model. On its latest balance sheet, Zoom reported $4.8 billion in cash and marketable securities, with net leverage at 0.2x EBITDA. That liquidity position underpins share repurchases—Zoom has authorized $1 billion of buybacks to date—and provides firepower for further strategic acquisitions in the AI space.

Zoom shares recently hit a new 52-week high on strong volume, with after-hours trading reflecting sustained investor interest following an upgrade by a major brokerage. Trading volume averaged 10 million shares per day over the past month, 60% above its year-to-date average. Analysts have raised annual recurring revenue (ARR) estimates by 5% to account for stronger enterprise renewals and upsells. The consensus price target implies upside of mid-teens percentage points, driven by accelerating AI adoption and international expansion in Europe and Asia Pacific.